Michael Verneris, MDEnriched profile
Professor of Pediatrics; Director of Bone Marrow Transplantation and Cellular Therapy; Barton Family Endowed Chair of Bone Marrow Transplant · University of Colorado School of Medicine / Children's Hospital Colorado, Department of Pediatrics - Hematology/Oncology and Bone Marrow Transplantation, Anschutz Medical Campus, Aurora, CO
Overview
Updated 14 Jul 2026
Michael Verneris, MD, is Professor of Pediatrics at University of Colorado School of Medicine / Children's Hospital Colorado, Department of Pediatrics - Hematology/Oncology and Bone Marrow Transplantation, Anschutz Medical Campus, Aurora, CO. The public record shows 497 publications with 23,009 citations (h-index 67), centered on Kidney Cancer / RCC, Sarcoma, Lymphoma. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 10 companies, 3 NIH-funded awards (2016–2020).
- Most recent indexed publication: 2025 · Blood advances
- Top research focus: Kidney Cancer / RCC
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 10 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 17 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- Study of Feasibility and Safety of UCD19 Chimeric Antigen Receptor (CAR) T Cells in Adult Subjects With Relapsed/Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (B-NHL)
Sponsor: University of Colorado, Denver
InvestigatorPhase 1CompletedNCT04240808 - T-Cell Depleted Double UCB for Refractory AML
Sponsor: Masonic Cancer Center, University of Minnesota
InvestigatorPhase 2TerminatedNCT01464359 - A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Sponsor: Center for International Blood and Marrow Transplant Research
InvestigatorRecruitingNCT01351545
Industry payments
Updated 14 Jul 2026
10 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Mesoblast, Inc.Program year20252 payments
- National Marrow Donor ProgramProgram year20252 payments
- Novartis Pharmaceuticals CorporationProgram year20253 payments
NIH funding
Updated 14 Jul 2026
3 NIH research awards on record, funded 2016–2020 per NIH RePORTER. The latest:
- BMT Core - Pediatric Transplantation and Cellular Therapy Consortium (PTCTC): Providing Clinical Trial Access For Children With Life Threatening Diseases
National Marrow Donor Program
FY2025$164,548UG1HL174426 - BMT Core - Pediatric Transplantation and Cellular Therapy Consortium (PTCTC): Providing Clinical Trial Access For Children With Life Threatening Diseases
National Marrow Donor Program
FY2024$184,489UG1HL174426 - Characterizing Innate Immune Dysregulation in Tonsils of Individuals with Down Syndrome
University of Colorado Denver
FY2020$3,038,439R01HL155691
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
13123 East 16th Ave, Aurora, CO 80045
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cumedicine.us ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cumedicine.us ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cumedicine.us ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucdenver.edu ↗
- Board Certified
Pediatric Hematology/Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
Editorial & leadership rolesjournal and society appointments
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →childrenscolorado.org ↗
- Co-Director
Tumor Host Interactions Program, University of Colorado Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗ - Translational Sciences Lead
Gates Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
Secondary affiliationsappointments beyond the home institution
- Director-Faculty
Hematology/Oncology Division, University of Colorado Denver - Anschutz Medical Campus
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucdenver.edu ↗ - Gates Biomanufacturing Facility (Gates Institute)
CU Anschutz - collaborator on canine CAR T-cell trial with Steven Dow
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.cuanschutz.edu ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.cuanschutz.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/michael-verneris-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/michael-verneris-1b74727
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Michael-R-Verneris-40034125
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
- 1,431
- publications
- 164
- h-index
- 8
- trials
Toni Choueiri, MD
Brigham and Women's Hospital
- 2,494
- publications
- 152
- h-index
- 12
- trials
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
- 1,588
- publications
- 150
- h-index
- 18
- trials
Fred Saad, MD
Centre Hospitalier de l’Université de Montréal
- 1,915
- publications
- 128
- h-index
- 7
- trials